The Sarcoma Foundation of America (SFA) is pleased to announce a research funding opportunity to provide one-year grants in the amount of $50,000, to support translational science research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. The grants are awarded on an annual cycle from June 1 to May 31 (the annual period of performance). Grant awards for the 2021 cycle will be made on June 1, 2021.
Bristol Myers Squibb Foundation and National Medical Fellowships—Diversity in Clinical Trials Career Development Program (DCTCDP)
In partnership, the Bristol Myers Squibb Foundation and National Medical Fellowships have created the Diversity in Clinical Trials Career Development Program (DCTCDP) aimed at increasing diversity in clinical trials.
Primary consideration in granting support is given to truly innovative, unique, patient-centered research that has the potential to positively impact the lives of cancer patients at the earliest opportunity. As time is not a luxury afforded to cancer patients, we demand that research projects approved for funding are activated within 6 months of funding upon official award notification and that they exert a patient impact within 3 years or less.
Lilly Grant Office—Healthcare professional education/Patient advocacy and Consumer education programs
As a commitment to improving patient care and providing valuable information to the medical and broader healthcare community, Lilly will accept the following grant requests:
- Healthcare professional education (priority will be given to accredited programs)
- Patient advocacy and Consumer education programs (e.g., disease-state education and awareness, screenings, etc.)
Funding may be requested in the form of support for an educational program, scientific awards, select fellowships, or charitable contributions. Lilly does not provide unrestricted grants or grants to individuals or
The focus of the Lilly Grant Office (LGO) will be on healthcare-related CME/CE programs as well as patient education and advocacy in the following therapeutic areas:
- Neuroscience - Migraine and Headache Disorders
- Chronic pain associated with osteoarthritis and chronic low back pain
Sanofi US is committed to funding high quality educational activities and materials in the therapeutic areas of interest to the company that have the potential to improve patient care and health outcomes. The purpose of an educational grant is to support an activity that encourages an educational interchange with respect to available scientific and medical information. Educational activities may or may not be accredited.
In addition to sponsoring its own research and research collaborations, Lilly has programs for considering external requests for Lilly provision of study drug and/or financial support for Investiga
Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and acade
Grants for IME for the following disease states: Disease States: Acute Myeloid Leukemia, Age-related Macular Degeneration, ALK-Positive Non-small cell lung cancer, basal cell carcinoma, bladder can
Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. RWJF is interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, RWJF welcomes ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.